1. Home
  2. SCLX vs GREE Comparison

SCLX vs GREE Comparison

Compare SCLX & GREE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SCLX
  • GREE
  • Stock Information
  • Founded
  • SCLX 2011
  • GREE 1937
  • Country
  • SCLX United States
  • GREE United States
  • Employees
  • SCLX N/A
  • GREE N/A
  • Industry
  • SCLX Biotechnology: Pharmaceutical Preparations
  • GREE Investment Bankers/Brokers/Service
  • Sector
  • SCLX Health Care
  • GREE Finance
  • Exchange
  • SCLX Nasdaq
  • GREE Nasdaq
  • Market Cap
  • SCLX 35.7M
  • GREE 31.7M
  • IPO Year
  • SCLX N/A
  • GREE N/A
  • Fundamental
  • Price
  • SCLX $16.46
  • GREE $2.07
  • Analyst Decision
  • SCLX Buy
  • GREE
  • Analyst Count
  • SCLX 2
  • GREE 0
  • Target Price
  • SCLX $245.00
  • GREE N/A
  • AVG Volume (30 Days)
  • SCLX 255.7K
  • GREE 389.0K
  • Earning Date
  • SCLX 08-13-2025
  • GREE 11-07-2025
  • Dividend Yield
  • SCLX N/A
  • GREE N/A
  • EPS Growth
  • SCLX N/A
  • GREE N/A
  • EPS
  • SCLX N/A
  • GREE N/A
  • Revenue
  • SCLX $44,236,000.00
  • GREE $59,246,000.00
  • Revenue This Year
  • SCLX $89.26
  • GREE N/A
  • Revenue Next Year
  • SCLX $203.95
  • GREE N/A
  • P/E Ratio
  • SCLX N/A
  • GREE N/A
  • Revenue Growth
  • SCLX N/A
  • GREE N/A
  • 52 Week Low
  • SCLX $3.60
  • GREE $0.58
  • 52 Week High
  • SCLX $39.90
  • GREE $3.84
  • Technical
  • Relative Strength Index (RSI)
  • SCLX 47.62
  • GREE 55.84
  • Support Level
  • SCLX $13.08
  • GREE $1.83
  • Resistance Level
  • SCLX $14.74
  • GREE $2.23
  • Average True Range (ATR)
  • SCLX 1.51
  • GREE 0.25
  • MACD
  • SCLX -0.07
  • GREE -0.02
  • Stochastic Oscillator
  • SCLX 55.24
  • GREE 53.34

About SCLX Scilex Holding Company

Scilex Holding Co is focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. The Company's commercial product, ZTlido (lidocaine topical system), is a prescription lidocaine topical product for relieving pain associated with postherpetic neuralgia, which is a form of post-shingles nerve pain. It is focused on commercializing Gloperba (colchicine USP) an oral solution, a prophylactic treatment for painful gout flares in adults. The Company's three product candidates are SP-102 or SEMDEXA viscous gel formulation of a used corticosteroid for epidural injections, SP-103 a Phase 2, triple-strength formulation of ZTlido, and SP-104, 4.5 mg Delayed Burst Release Low Dose Naltrexone Hydrochloride (DBR-LDN) Capsule.

About GREE Greenidge Generation Holdings Inc.

Greenidge Generation Holdings Inc owns and operates a vertically integrated cryptocurrency data center. Company operates in three segments: Crypto Mining, Datacenter Hosting, Power and Capacity. The company owns and operates facilities at two locations: the Torrey, New York, and Spartanburg, South Carolina. The cryptocurrency data center operations generate revenue in the form of bitcoin by earning bitcoin as rewards and transaction fees for supporting the bitcoin network with application-specific integrated circuit computers (ASICs or miners) owned or leased by the company.

Share on Social Networks: